Clinical Trials Browser

Withdrawn × Tamoxifen × CNS × Clear all

NCT04200066 2022-08-22

A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent Glioblastoma

Phase 1 Withdrawn

Brain Neoplasms, Glioblastoma